Acorda Therapeutics, Inc.

CIK 1008848 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Acorda Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 13, 202415-12G0001193125-24-199373
Aug 12, 2024EFFECT9999999995-24-002489
Aug 12, 2024EFFECT9999999995-24-002488
Aug 12, 2024EFFECT9999999995-24-002485
Aug 12, 2024EFFECT9999999995-24-002487
Aug 12, 2024EFFECT9999999995-24-002486
Aug 9, 2024S-8 POS0000950170-24-094694
Aug 9, 2024POS AM0000950170-24-094668
Aug 9, 2024S-8 POS0000950170-24-094688
Aug 9, 2024S-8 POS0000950170-24-094671
Aug 9, 2024S-8 POS0000950170-24-094682
Aug 9, 2024S-8 POS0000950170-24-094697
Aug 9, 2024POS AM0000950170-24-094661
Aug 9, 2024S-8 POS0000950170-24-094701
Aug 9, 2024S-8 POS0000950170-24-094776
Aug 9, 2024S-8 POS0000950170-24-094680
Aug 9, 20248-K0000950170-24-094382
Aug 9, 2024S-8 POS0000950170-24-094712
Aug 9, 2024S-8 POS0000950170-24-094705
Aug 9, 2024S-8 POS0000950170-24-094696
Aug 9, 2024S-8 POS0000950170-24-094675
Aug 9, 2024S-8 POS0000950170-24-094708
Aug 9, 2024S-8 POS0000950170-24-094699
Aug 9, 2024POS AM0000950170-24-094672
Aug 9, 2024S-8 POS0000950170-24-094690